These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 16021797)

  • 1. Bounty-hunting and finder's fees.
    Christensen JA; Orlowski JP
    IRB; 2005; 27(3):16-9. PubMed ID: 16021797
    [No Abstract]   [Full Text] [Related]  

  • 2. Legal and ethical issues associated with patient recruitment in clinical trials: the case of competitive enrolment.
    Caulfield T
    Health Law Rev; 2005; 13(2-3):58-61. PubMed ID: 16459415
    [No Abstract]   [Full Text] [Related]  

  • 3. Physicians, finder's fees and free, informed consent.
    Flegel KM
    CMAJ; 1997 Nov; 157(10):1373-4. PubMed ID: 9371067
    [No Abstract]   [Full Text] [Related]  

  • 4. Conflict of interest in clinical research: direct payment to the investigators for finding human subjects and health information.
    Puttagunta PS; Caulfield TA; Griener G
    Health Law Rev; 2002; 10(2):30-2. PubMed ID: 15739309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conflict of interest in human subjects research.
    Groeger JS; Barnes M
    Crit Care Med; 2003 Mar; 31(3 Suppl):S137-42. PubMed ID: 12626959
    [No Abstract]   [Full Text] [Related]  

  • 6. Finder's fees for research subjects.
    Lind SE
    N Engl J Med; 1990 Jul; 323(3):192-5. PubMed ID: 2362609
    [No Abstract]   [Full Text] [Related]  

  • 7. Commentary: Per capita payments in clinical trials: reasonable costs versus bounty hunting.
    Hall MA; Friedman JY; King NM; Weinfurt KP; Schulman KA; Sugarman J
    Acad Med; 2010 Oct; 85(10):1554-6. PubMed ID: 20881671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why I oppose drug company payment of physician/investigators on a per patient/subject basis.
    Roizen R
    IRB; 1988; 10(1):9-10. PubMed ID: 11658990
    [No Abstract]   [Full Text] [Related]  

  • 9. Expanding disclosure of conflicts of interest: the views of stakeholders.
    Brody BA; Anderson C; McCrary SV; McCullough L; Morgan R; Wray N
    IRB; 2003; 25(1):1-8. PubMed ID: 12833897
    [No Abstract]   [Full Text] [Related]  

  • 10. Conflicts of interest in medical research: how much conflict should exceed legal boundaries?
    Klanica K
    J Biolaw Bus; 2005; 8(3):37-45. PubMed ID: 16459426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doctors' links with investors raise concerns.
    Saul S; Anderson J
    N Y Times Web; 2005 Aug; ():A1,C6. PubMed ID: 16134280
    [No Abstract]   [Full Text] [Related]  

  • 12. Finder's fees may compromise the provider-patient relationship.
    McGough H
    IRB; 1991; 13(1-2):23. PubMed ID: 11653979
    [No Abstract]   [Full Text] [Related]  

  • 13. Ten steps to developing a national agenda to address financial conflicts of interest in industry sponsored clinical research.
    Tereskerz PM; Moreno J
    Account Res; 2005; 12(2):139-55. PubMed ID: 16220626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Researcher said his colleague should have revealed possible conflicts of interest.
    Maloney DM
    Hum Res Rep; 2005 Jan; 20(1):8. PubMed ID: 15810184
    [No Abstract]   [Full Text] [Related]  

  • 15. The case for per patient payments.
    Lewis JP
    IRB; 1988; 10(5):9. PubMed ID: 11650075
    [No Abstract]   [Full Text] [Related]  

  • 16. Managing physician financial conflicts of interest in clinical trials conducted in the private practice setting.
    Williams KM
    Food Drug Law J; 2004; 59(1):45-77. PubMed ID: 15190925
    [No Abstract]   [Full Text] [Related]  

  • 17. All above board: openness is the only option if science is to maintain its integrity.
    New Sci; 2004 Mar 6-12; 181(2437):3. PubMed ID: 15139348
    [No Abstract]   [Full Text] [Related]  

  • 18. The perverse consequences of a proposed global tax on research.
    MacDonald C; Walton N
    Am J Bioeth; 2010 Jun; 10(6):46-7. PubMed ID: 20526972
    [No Abstract]   [Full Text] [Related]  

  • 19. Guidance on financial disclosure requirements.
    Maloney DM
    Hum Res Rep; 2001 May; 16(5):4. PubMed ID: 11833562
    [No Abstract]   [Full Text] [Related]  

  • 20. Putting the "ethics" into "research ethics".
    Spike J
    Am J Bioeth; 2005; 5(1):51-3; author reply W15-8. PubMed ID: 16036663
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 28.